CEV offers its expertise on clinical trial conduct, the recruitment of the study participants by providing a database of more than 3000 subjects, the execution of the vaccine studies in a Phase I-IV clinical trial unit according to ICH-GCP, trained personnel, analysis and reporting of the data, and the needed GLP facilities to quantify humoral and cellular immune responses induced by the vaccines.
- a multidisciplinary research team.
- Platform for vaccine clinical studies: phase I-IV.
- 'bedside to bench' delivery timelines to quickly adjust the vaccine development process.
⇒ A combination of high quality infrastructure with state-of-the-art